Vecuronium Temporary Vial Cap Change Notification - June 3, 2020
Fresenius Kabi USA Ketorolac Tromethamine Injection USP US Recall Packet - April 20, 2020
U.S. Manufacturing Expansion Communication - December 13, 2019
U.S. Manufacturing Expansion Communication (Novaplus) - December 13, 2019
Enoxaparin NDC Update Communication - November 20, 2019
Enoxaparin NDC Update Communication (Novaplus) - November 20, 2019
Parenteral Nutrition Light Protection for Children Under 2 - November 4, 2019
Heparin Supply Update - July 9, 2019
Fluorouracil, US Recall Packet - June 28, 2019
Fluorouracil, NONCONTIGUOUS US Recall Packet - June 28, 2019
Sodium Chloride Noncontiguous US Recall Packet – Updated December 3, 2018
Simplist® Packaging Change Information – April 2, 2018
Melphalan Hydrochloride for Injection Package Insert – March 16, 2018
Fresenius Kabi Responds to Drug Shortages – March 16, 2018
Simplist® Supply Update – March 14, 2018
Fresenius Kabi USA Vecuronium Bromide US Recall Packet – January 19, 2018
Fresenius Kabi USA Vecuronium Bromide Noncontinugous US Recall Packet – January 19, 2018
IV Solutions DHP Letter – November 17, 2017
Glycophos DHP Letter – November 6, 2017
Glycophos FAQ – November 2, 2017
Midazolam Injection Recall Packet US – October 30, 2017
Midazolam Injection Recall Packet Noncontiguous US – October 30, 2017
Sodium Phosphates IMPORTANT CORRECTION OF DRUG INFORMATION Letter – August 30, 2017
Fluphenazine Decanoate Injection Drug Recall Letter – March 16, 2017
Midazolam Hydrochloride Injection Drug Recall Letter – December 16, 2016
Xylocaine & Sensorcaine with Epinephrine Important Drug Information Letter - November 14, 2016
Bleomycin for Injection Important Drug Information Letter - June 15, 2016
Cisatracurium Besylate Injection Recall Letter - April 5, 2016
Lidocaine Customer Letter - October 19, 2015
Calcium Gluconate Injection, USP Customer Letter - April 2015
Scopolamine Hydrobromide Injection, USP Supply Letter - February 2015
Vasopressin Injection, USP Customer Letter - February 2015
Midazolam Added to Controlled-Distribution Program - August 2013
Voluven® Important Drug Warning - June 26, 2013